Mucosal delivery systems of antihypertensive drugs: A practical approach in general practice

Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
Lukasz P BialyIzabela Mlynarczuk-Bialy

Abstract

Patients who are unable to receive oral medication (p.o.) are a major problem in outpatient settings, especially in home health care systems. Mucosal administration of drugs offers an alternative to the oral route, especially when the parenteral mode cannot be used. There are three main pathways of mucosal administration: sublingual/buccal, intranasal and rectal. We discuss the possibility of mucosal delivery of antihypertensive drugs. Perindopril arginine and Amlodipine besylate are registered in the EU as orodispersible tablets for oromucosal delivery, however, they are not available in all countries. For this reason, we describe other drugs suitable for mucosal delivery: Captopril and Nitrendipine in the sublingual system and Metoprolol tartrate, Propranolol and Furosemide by the transrectal route. Based on the published data and common clinical practice we discuss the use of mucosal delivery systems of all these antihypertensive drugs with special attention to their pharmacokinetics. We illustrate this mini-review with a case report of the prolonged-term use of mucosal delivery of sublingual Captopril and Nitrendipine combined with rectal Metoprolol tartrate and Furosemide in a patient with severe hypertension unable to rec...Continue Reading

References

Jan 1, 1976·European Journal of Clinical Pharmacology·Y A WeissJ M Alexandre
Jan 1, 1992·Cardiology·D R Abernethy
Oct 1, 1991·Chemical & Pharmaceutical Bulletin·T OgisoK Yamashita
Jan 1, 1988·Journal of General Internal Medicine·J B Reuler, G J Magarian
Sep 1, 1971·British Journal of Pharmacology·J D Fitzgerald, S R O'Donnell
Feb 1, 1984·Clinical Pharmacology and Therapeutics·L G de LeedeD D Breimer
Jan 1, 1984·European Journal of Clinical Pharmacology·M M HammarlundB Odlind
Apr 29, 1999·Drug Development and Industrial Pharmacy·L Nair, H N Bhargava
May 20, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·J M Ryu ShimCK
Feb 24, 2001·The Journal of Pharmacy and Pharmacology·E J KimM G Lee
Apr 27, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Szilvia BerkóIstván Erós
Jul 20, 2002·Clinical Pharmacokinetics·Hao ZhangJames B Streisand
Nov 21, 2002·JAMA : the Journal of the American Medical Association·Jackson T WrightUNKNOWN African American Study of Kidney Disease and Hypertension Study Group
Dec 11, 2002·Journal of General Internal Medicine·David Cherney, Sharon Straus
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Sep 19, 2003·Lancet·K M Fox, UNKNOWN EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
Jan 22, 2005·Critical Reviews in Therapeutic Drug Carrier Systems·Yourong FuKinam Park
Mar 15, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alamdar Hussain, Fakhrul Ahsan
Nov 7, 2006·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Philippe Meurin
May 24, 2007·Current Medical Research and Opinion·Elwira Telejko
Sep 19, 2007·British Journal of Clinical Pharmacology·Laurent HaegeliStephan Krähenbühl
Apr 2, 2008·The New England Journal of Medicine·Nigel S BeckettUNKNOWN HYVET Study Group
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
May 20, 2009·Journal of Hypertension·Pierluigi CostanzoMassimo Chiariello
Jan 11, 2011·Indian Journal of Pharmaceutical Sciences·B P PatelR S Thakor
Mar 5, 2011·Advanced Drug Delivery Reviews·Vanessa HearndenMartin H Thornhill
Jul 1, 2010·Journal of Natural Science, Biology, and Medicine·Paramita Dey, Sabyasachi Maiti
Dec 12, 2012·International Urogynecology Journal·Sushma Srikrishna, Linda Cardozo
Feb 6, 2013·International Journal of Clinical Pharmacology and Therapeutics·Milko RadicioniChiara Leuratti
May 15, 2013·Clinical Pharmacology and Therapeutics·C M BlakeP Nagele
May 28, 2013·International Journal of Pharmaceutics·Agnese MiroFabiana Quaglia
Apr 25, 2014·Drug Delivery·Amal El Sayeh F Abou el ElaEhsan H Ibrahim

❮ Previous
Next ❯

Citations

Sep 25, 2019·European Journal of Clinical Nutrition·Claire E WilliamsBernard M Corfe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.